
Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

